Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2007-06-05
2007-06-05
Anderson, Rebecca (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
active
11200713
ABSTRACT:
The present invention relates to a process for preparing 2-amino-thiazoline derivatives of formula (II):in which either Y is a methylene (CH2) and X is chosen from the following groups: O, NH, (C1–C4) N-Alkyl, N-Bn, N-Ph, N-(2-Py), N-(3-Py), N-(4-Py), N-2-pyrimidyl, N-5-pyrimidyl, S, SO, SO2, CH2or CHPh; or Y is a carbonyl (C═O) and X is chosen from the following groups: NH, N-Ph, N-(2-Py), N-(3-Py), N-(4-Py), N-2-pyrimidyl or N-5-pyrimidyl.
REFERENCES:
patent: 6451821 (2002-09-01), Carry et al.
patent: 6699867 (2004-03-01), Bigot et al.
patent: 2004/0192745 (2004-09-01), Ehrenreich et al.
patent: 0 307 837 (1989-03-01), None
patent: WO 94/12165 (1994-06-01), None
patent: WO 95/11231 (1995-04-01), None
patent: WO 96/14842 (1996-05-01), None
patent: WO 98/22494 (1998-05-01), None
Bagasra, O., et al., Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis, Proc. Natl. Acad. Sci., vol. 92, 1995, pp. 12041-12045.
Cardona, M. L., et. al., Synthesis of Natural Polyhydroxystilbenes, Tetrahedron, vol. 42, No. 10, 1986, pp. 2725-2730.
Chabrier, P., et. al., Nitric oxide synthases: targets for therapeutic strategies in neurological diseases, Cell. Mol. Life Sci., vol. 55, 1999, pp. 1029-1035.
Creeke, P. I., et. al., Synthesis and Elaboration of Heterocycles Via Iodocyclisation of Unsaturated Thioureas, Tetrahedron Letters, vol. 30, No. 33, 1989, pp. 4435-4438.
Einsiedel, J., et. al., Benzamide Bioisosteres Incorporating Dihydroheteroazole Substructures: EPC Synthesis and SAR Leading to a Selective Dopamine D4 Receptor Partial Agonist (FAUC 179), Bioorganic & Medicinal Chemistry Letters, vol. 11, No. 18, 2001, pp. 2533-2536.
Gilgun-Sherki, Y., et. al., Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis, Brain Reasearch, vol. 989(2), 2003, pp. 196-204.
Giovannoni, G., et. al., The potential role of nitric oxide in multiple sclerosis, Multiple Sclerosis, vol. 4(3), 1998, pp. 212-216.
Keita, H., et. al., Anesthetic concentrations of riluzole inhibit neuronal nitric oxide synthase activity, but not expression, in the rat hippocampus, Brain Research, vol. 881(2), 2000, pp. 237-240.
Kim, B. Moon, et. al., Efficient Hydroiysis of Beta-Aminosulfamic Acids Using a Lewis Acid and a Thiol for the Synthesis of 2,3-Diaminopropanoate Derivatives, Tetrahedron Letters, vol. 39, No. 30, 1998, pp. 5381-5384.
Lacomblez, et. al., Dose-ranging study of riluzole in amyotrophic lateral sclerosis, The Lancet, vol. 347(9013), 1996, pp. 1425-1431.
Lassen, L., et. al., Nitric oxide synthase inhibition in migraine, The Lancet, vol. 349, 1997, pp. 401-402.
Lee, T. J. F, et. al., Nitric Oxide and the Cerebral vascular Function, J. Biomed. Sci., vol. 7(1), 2000, pp. 16-26.
Masukawa. T., et. al., Role of Nitric Oxide in the Convulsions Following the Coadministration of Enoxacin with Fenbufen in Mice, Jpn. J. Pharmacol., vol. 76(4), 1998, pp. 425-429.
Miljkovic, D., et. al., Leflunomide inhibits activation of inducible nitric oxide synthase in rat astrocytes, Brain Research, vol. 889(1-2), pp. 331-338 2001.
Milos Hudlicky, et. al., Oxidations In Organic Chemistry, American Chemical Society (1990, pp. 252-263, vol. 186).
Moncada, S., et. al., Biosynthesis of Nitric Oxide From L-Arginine A Patheway for the Regulation of Cell Function and Communication, Biochemical Pharmacology, vol. 38, No. 11, 1989, pp. 1709-1715.
Perez, M., et. al., FeCl3-Catalyzed Connugate Addition of Secondary Amines, Imidazole and Pyrazole to Methyl 2-Acetamidoacrylate, Preparation of Beta-dialkylamino-alpha-alanine and Beta-(N-Heteroaryl)-alpha-alanine Derivatives, Tetrahedron, vol. 51, No. 30, 1995, pp. 8355-8362.
Pozza, M., et. al., Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution, Brain Research, vol. 8551), 2000, pp. 39-46.
Moncada, S., et. al., Bioynthesis Of Nitric Oxide From L-Arginine A Pathway For The Regulation Of Cell Function And Communication, Biochemical Pharmacology, (1989, pp. 1709-1715, vol. 38, No. 11).
Singer, M., et. al., Synthesis of (R)- and (S)-4′-Acetoxyolivetol [(R)- and (S)-5-(4′-Acetoxypentyl)-1,3-benzenediol]: Key Intermediates in the Synthesis of Tetrahydrocannabinol Derivatives, Synthesis, 1994, pp. 486-488.
Stanislaus, R., et. al., Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin, Neuroscience Letters, vol. 269, 1999, pp.71-74.
Torreilles, F., et. al., Neurodogenerative disorders: the role of peroxynitrite, Brain Research Reviews, vol. 30(2), 1999, pp. 153-163.
Bigot Antony
Carry Jean-Christophe
Mignani Serge
Anderson Rebecca
Aventis Pharma SA
Newman Irving
LandOfFree
Use of 2-amino-thiazoline derivatives as inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 2-amino-thiazoline derivatives as inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2-amino-thiazoline derivatives as inhibitors of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3872636